NUZ 7.50% 18.5¢ neurizon therapeutics limited

Ann: Receipt of GMP Grade Tablets for Phase II Trials, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,419 Posts.
    lightbulb Created with Sketch. 6390
    Receipt of GMP Grade Monepantel Tablets for Phase IIDog Cancer Trials

    GMP monepantel tablets arrive from US to subsidiary Epichem Pty Ltd

    • Stability studies for shelf-life support commencement of trial

    Shipment of tablets to veterinarians scheduled to commence next week

    • Anti-cancer testing to commence in dogs with B cell lymphoma26 August 2019 – Perth, Australia: PharmAust Ltd (ASXAA), a clinical-stage oncologycompany, is pleased to announce the receipt of 7,750 of its newly developed GMP grademonepantel tablets.

    The tablets have been logged into Epichem’s inventory receipt systemsready for shipment to veterinarians conducting the phase II trial as required. Delivery to theveterinarians is expected to commence this week.Shipment of the GMP monepantel tablets has occurred following rigorous tests demonstratingthat all tablets produced in the scaled manufacturing run are consistent in their size, shape andcontent.

    Furthermore, the tablets have been on accelerated stability studies and shown to passshelf-life requirements supporting that their performance will not be compromised underhandling conditions expected following distribution to veterinarians and then to pet owners.

    PharmAust’s Chief Scientific Officer Dr Richard Mollard commented, “PharmAust is pleased toaccept delivery of the newly developed tablets on schedule at its Epichem facility. Furthermore,PharmAust is looking forward to providing these tablets to veterinarians and commencing thePhase II study, testing anti-cancer efficacy in pet dogs with B cell lymphoma


    https://hotcopper.com.au/data/attachments/1700/1700284-3da35864d1a4450e073d1eb464ab1d9c.jpg
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
(20min delay)
Last
18.5¢
Change
-0.015(7.50%)
Mkt cap ! $90.96M
Open High Low Value Volume
20.0¢ 20.0¢ 18.5¢ $115.7K 598.1K

Buyers (Bids)

No. Vol. Price($)
9 593392 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 4355 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.